Shopping Cart
- Remove All
Your shopping cart is currently empty
Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $232 | In Stock | |
| 5 mg | $581 | In Stock | |
| 10 mg | $930 | In Stock | |
| 25 mg | $1,581 | In Stock | |
| 50 mg | $2,370 | In Stock |
| Description | Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis. |
| In vivo | Romosozumab (30 mg/kg twice weekly for 10 weeks) induces the transformation of bone trabecular rod-like structures to plate-like structures in cynomolgus monkeys. [1] In mature cynomolgus monkeys undergoing ovariectomy for 4 months, Romosozumab (3 mg/kg and 30 mg/kg once weekly for 6 or 12 months) was able to enhance bone mass, optimize bone structure, and improve bone strength while maintaining bone quality. [2] |
| Synonyms | CDP-7851, CDP7851, AMG-785, AMG785 |
| Cas No. | 909395-70-6 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.